JAN 27, 2017 1:49 PM PST

A.I. on Par With Doctors in Diagnosing Melanoma

WRITTEN BY: Xuan Pham

Can a smartphone be smart enough to warn users if their mole is actually deadly skin cancer? Not quite yet, but scientists from Stanford are marching in that direction. Recently, they made a huge step by developing and training an artificial intelligence (AI) software to diagnose melanoma. The AI, researchers say, has nearly the same accuracy as trained doctors.

Motivated by the desire for universal access to health care, doctors repurposed an AI software from Google that could differentiate between pictures of cats versus dogs. Using this software, the team trained the AI on database of nearly 130,000 images of skin conditions, curated to represent over 2,000 different diseases. This allowed the machine to learn the hallmarks of skin abnormalities. And instead of cats versus dogs, the machine can differentiate between benign moles and malignant melanomas.

“We realized it was feasible, not just to do something well, but as well as a human dermatologist,” said Sebastian Thrun, an adjunct professor in the Stanford Artificial Intelligence Laboratory, and the study’s senior author. “That’s when our thinking changed. That’s when we said, ‘Look, this is not just a class project for students, this is an opportunity to do something great for humanity.’”

Stanford scientists then pitted their AI against 21 trained dermatologists. They found that the AI performed as good as the human doctors. The AI achieved “performance on par with all tested experts…, demonstrating an artificial intelligence capable of classifying skin cancer with a level of competence comparable to dermatologists,” the authors wrote in their paper, published in Nature

While doctors and pathologists are still quite vital to confirming the diagnosis, the Stanford team are excited about the prospects of integrating the AI for public use. In particular, they hope to incorporate the technology into smartphones, taking full advantage of the widespread use of these mobile devices.

"The application of AI to healthcare is, we believe, an incredibly exciting area of research that can be leveraged to achieve a great deal of societal good," said Andre Esteva, the study’s lead author. "One particular route that we find exciting is the use of this algorithm on a mobile device, but to achieve this we would have to build an app and test its accuracy directly from a mobile device."

On an even grander scale, Esteva hopes medical AI may soon apply to other diseases other than melanoma. “Everyone will have a supercomputer in their pockets with a number of sensors in it, including a camera. What if we could use it to visually screen for skin cancer? Or other ailments?”

Before that happens, however, the Stanford team’s melanoma AI detector must be rigorously tested in clinics. And even then, it may be unlikely that AI will completely replace human doctors. And this may just be for the better. 

Additional sources: Stanford University,  BBC

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
DEC 09, 2019
Cancer
DEC 09, 2019
Hair dyes associated with increased risk of breast cancer
Research recently published in the International Journal of Cancer suggests that certain hair dyes and chemical relaxants are associated with breast cancer...
DEC 25, 2019
Drug Discovery & Development
DEC 25, 2019
New Drug to Make Breast Cancer Treatment More Affordable
The US Food and Drug Administration has granted accelerated approval to new breast cancer drug, trastuzumab deruxtecan. The drug’s increasing recogni...
JAN 15, 2020
Cell & Molecular Biology
JAN 15, 2020
Cell Division Research Reveals More About a Protein That's Elevated in Cancer
Cell division is a carefully regulated process, cancer is the result when it gets out of control....
FEB 14, 2020
Immunology
FEB 14, 2020
Rewired natural killer cells show promising results in leukemia patients
Natural killer (NK) cells are a subset of white blood cells that are key players in the innate immune system, orchestrating host-rejection responses agains...
FEB 13, 2020
Cancer
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new ally to brain tumors: Ebola. Yes, yo...
FEB 19, 2020
Immunology
FEB 19, 2020
Testing the Immune Response to Ovarian Cancer Treatment
There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean better diagnostics, and better diag...
Loading Comments...